These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 16630721)

  • 1. Crystal structure of a low molecular weight activator Blm-pep with yeast 20S proteasome - insights into the enzyme activation mechanism.
    Witkowska J; Giżyńska M; Grudnik P; Golik P; Karpowicz P; Giełdoń A; Dubin G; Jankowska E
    Sci Rep; 2017 Jul; 7(1):6177. PubMed ID: 28733623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periodate-triggered cross-linking reveals Sug2/Rpt4 as the molecular target of a peptoid inhibitor of the 19S proteasome regulatory particle.
    Lim HS; Cai D; Archer CT; Kodadek T
    J Am Chem Soc; 2007 Oct; 129(43):12936-7. PubMed ID: 17929816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxadiazole-isopropylamides as potent and noncovalent proteasome inhibitors.
    Ozcan S; Kazi A; Marsilio F; Fang B; Guida WC; Koomen J; Lawrence HR; Sebti SM
    J Med Chem; 2013 May; 56(10):3783-805. PubMed ID: 23547706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α,β-Unsaturated carbonyl system of chalcone-based derivatives is responsible for broad inhibition of proteasomal activity and preferential killing of human papilloma virus (HPV) positive cervical cancer cells.
    Bazzaro M; Anchoori RK; Mudiam MK; Issaenko O; Kumar S; Karanam B; Lin Z; Isaksson Vogel R; Gavioli R; Destro F; Ferretti V; Roden RB; Khan SR
    J Med Chem; 2011 Jan; 54(2):449-56. PubMed ID: 21186794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of boron peptide analogues of Belactosin C as proteasome inhibitors.
    Nakamura H; Watanabe M; Ban HS; Nabeyama W; Asai A
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3220-4. PubMed ID: 19428245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-terminal-prolonged vinyl ester-based peptides as selective proteasome beta1 subunit inhibitors.
    Baldisserotto A; Destro F; Vertuani G; Marastoni M; Gavioli R; Tomatis R
    Bioorg Med Chem; 2009 Aug; 17(15):5535-40. PubMed ID: 19577931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixing of peptides and electrophilic traps gives rise to potent, broad-spectrum proteasome inhibitors.
    Verdoes M; Florea BI; van der Linden WA; Renou D; van den Nieuwendijk AM; van der Marel GA; Overkleeft HS
    Org Biomol Chem; 2007 May; 5(9):1416-26. PubMed ID: 17464411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel beta-lactam derivatives: potent and selective inhibitors of the chymotrypsin-like activity of the human 20S proteasome.
    Imbach P; Lang M; García-Echeverría C; Guagnano V; Noorani M; Roesel J; Bitsch F; Rihs G; Furet P
    Bioorg Med Chem Lett; 2007 Jan; 17(2):358-62. PubMed ID: 17095212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based design of derivatives of tyropeptin A as the potent and selective inhibitors of mammalian 20S proteasome.
    Momose I; Umezawa Y; Hirosawa S; Iinuma H; Ikeda D
    Bioorg Med Chem Lett; 2005 Apr; 15(7):1867-71. PubMed ID: 15780623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of lipopeptides for inhibiting 20S proteasomes.
    Basse N; Papapostolou D; Pagano M; Reboud-Ravaux M; Bernard E; Felten AS; Vanderesse R
    Bioorg Med Chem Lett; 2006 Jun; 16(12):3277-81. PubMed ID: 16630721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 20S proteasome and its inhibitors: crystallographic knowledge for drug development.
    Borissenko L; Groll M
    Chem Rev; 2007 Mar; 107(3):687-717. PubMed ID: 17316053
    [No Abstract]   [Full Text] [Related]  

  • 12. Archaeal proteasomes and other regulatory proteases.
    Maupin-Furlow JA; Gil MA; Humbard MA; Kirkland PA; Li W; Reuter CJ; Wright AJ
    Curr Opin Microbiol; 2005 Dec; 8(6):720-8. PubMed ID: 16256423
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.